Eldepryl Capsules and Ibritumomab Intravenous
Determining the interaction of Eldepryl Capsules and Ibritumomab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: selegiline
Brand name: Eldepryl, Zelapar, Emsam
Synonyms: Eldepryl
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab, Ibritumomab Tiuxetan
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Eldepryl Capsules-Ibritumomab Tiuxetan
- Eldepryl Capsules-Ibrutinib
- Eldepryl Capsules-Ibrutinib Capsules
- Eldepryl Capsules-Ibrutinib Tablets
- Eldepryl Capsules-Ibu
- Eldepryl Capsules-IBU Tablets
- Ibritumomab Intravenous-Eldepryl Oral
- Ibritumomab Intravenous-Eldepryl Tablets
- Ibritumomab Intravenous-ELenzaPatch
- Ibritumomab Intravenous-Elepsia XR
- Ibritumomab Intravenous-Elestrin
- Ibritumomab Intravenous-Elestrin Transdermal